Anakinra in Recurrent Pericarditis: Current Evidence on Clinical Use, Effectiveness, and Safety
{{output}}
Anakinra is a recombinant human interleukin 1 receptor antagonist that competes and blocks the biologic effects of interleukin 1, reducing systemic inflammatory responses. In the 2015 guidelines for the diagnosis and management of pericardial diseases of the E... ...
